arrow_back Back Filing freshness 10-K FY 2026 SEC EDGAR

Prestige Consumer Healthcare Inc.

PBH
$54.87 ▲ +0.50 (+0.92%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
18 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
70
Health
Good
Bullish
auto_awesome

Analytical Summary

Prestige Consumer Healthcare Inc. shows strong fundamentals with top-quartile Profit Margin (%) and Operating Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $2.7B
Dividend Yield
Revenue Growth -4.3%
Op. Margin 28.4%
ROIC 7.9%
FCF / Share $5.09
Trailing P/E 14.0x
Price / Book 1.4x
FCF Yield 9.3%
Debt / Equity 0.53
info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.09B
↓ -4.3%
Net Income Profit after all expenses
$190.30M
↓ -11.3%
Operating Margin Operating profit as % of sales
28.4%
↓ -4.0% 93th
FCF / Share Free cash flow per share
$5.09
↑ +3.9%
Long-Term Debt Long-term obligations
$993.95M
— +0.2%
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
87
Returns
63
Financial Health
58
Cash Quality
71

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 66 quarters